Automated workflow solution to manage third-party relationships
Life sciences companies face increasing regulatory scrutiny, more complex supply chains and networks, and specific risks associated with third parties. They need a risk-based approach to assess their relationships with third parties that focuses not only on the broad risks affecting every sector but also the risks specific to their industry.
Control Risks is one of the most established global providers of corporate intelligence and due diligence services. VANTAGE for life sciences employs our market-leading proprietary research methodology to enable clients to undertake proportionate due diligence depending on the level of risk. We add pharmaceutical and life sciences research and targeted watch-list/database checks to provide a third-party due diligence solution that meets the regulatory and compliance needs of organisations operating in these areas.
Designed to support the particular requirements of life sciences compliance teams, VANTAGE for life sciences draws upon Control Risks’ global network of in-country experts and trusted sources, and over 30 years of experience working with the world’s top life sciences companies.
Screening solutions for life sciences professionals:
Identifying potential conflicts of interest and health care provider (HCP) issues of concern.
Identifying relevant historical and active litigation for general and life sciences specific categories, including Medical Malpractice, Negligence, Drug Effects, Healthcare Professionals, Medicines Devices & Procedures.
Actively monitoring and alerting of early litigation and case progression across a portfolio of third parties.
Our compliance and investigations business maintains the industry’s largest specialised public-records research team, consisting of local experts from a variety of regions and backgrounds. This ensures we constantly identify and evaluate new sources of information when gathering intelligence.